Study immune targets in cat and dust-mite allergic airway inflammation
Part of Immune system & allergy, Lungs & breathing clinical trials.
This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18–50.
- You do not smoke (less than 5 pack-years total, and none in the last 5 years).
- You are willing to consent and join study interviews with the lead researcher.
- You have allergy confirmed by a skin prick test to cat or dust mite.
- Your breathing tests must meet the study’s cutoffs (FEV1 around 75–90% predicted depending on group).
- You must avoid certain recent medications and illnesses (like recent asthma flare, steroid changes, antibiotics, or antihistamines).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at airway samples from people with asthma and healthy volunteers. It helps researchers understand what causes airway problems and could lead to better treatments.
This study looks at brain inflammation in people with mild asthma who are also allergic to common triggers like cats, dust mites, or ragweed. It uses MRI scans to see if a certain brain cell activity is different, which may help us understand asthma better and lead to new treatments.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
This study screens adults to better understand and manage asthma and allergic diseases. It may help identify treatments or management strategies that improve quality of life.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.